-
Notifications
You must be signed in to change notification settings - Fork 14
TumorPathologyEvent_MorphologyCode
Julien Guérin edited this page Jan 26, 2021
·
6 revisions
| Attribute | Value |
|---|---|
| ObjectClass | TumorPathologyEvent |
| ObjectProperty | MorphologyCode |
| DataElementConcept | TumorPathologyEvent_MorphologyCode |
| ObjectPropertyLabelEN | Morphology Code |
| ObjectPropertyLabelFR | Code Morphologie / Lésion |
| DataElementConceptDefEN | International code of lesion / histological type / tumor morphology of the tumoral event |
| DataElementConceptDefFR | Code international de la lésion / type histologique / morphologie de l'événement tumoral |
| Attribute | Value |
|---|---|
| FormatConceptualDomain | String |
| Required | mandatory |
| Attribute | Value |
|---|---|
| Examples |
| ValueMeaning | LabelValueMeaning |
|---|---|
| ICDO3:8000/0 | Neoplasm, benign |
| ICDO3:8000/1 | Neoplasm, uncertain whether benign or malignant |
| ICDO3:8000/3 | Neoplasm, malignant |
| ICDO3:8000/6 | Neoplasm, metastatic |
| ICDO3:8000/9 | Neoplasm, malignant, uncertain whether primary or metastatic |
| ICDO3:8001/0 | Tumor cells, benign |
| ICDO3:8001/1 | Tumor cells, uncertain whether benign or malignant |
| ICDO3:8001/3 | Tumor cells, malignant |
| ICDO3:8002/3 | Malignant tumor, small cell type |
| ICDO3:8003/3 | Malignant tumor, giant cell type |
| ICDO3:8004/3 | Malignant tumor, spindle cell type |
| ICDO3:8005/0 | Clear cell tumor, NOS |
| ICDO3:8005/3 | Malignant tumor, clear cell type |
| ICDO3:8010/0 | Epithelial tumor, benign |
| ICDO3:8010/2 | Carcinoma in situ, NOS |
| ICDO3:8010/3 | Carcinoma, NOS |
| ICDO3:8010/6 | Carcinoma, metastatic, NOS |
| ICDO3:8010/9 | Carcinomatosis |
| ICDO3:8011/0 | Epithelioma, benign |
| ICDO3:8011/3 | Epithelioma, malignant |
| ICDO3:8012/3 | Large cell carcinoma, NOS |
| ICDO3:8013/3 | Large cell neuroendocrine carcinoma |
| ICDO3:8014/3 | Large cell carcinoma with rhabdoid phenotype |
| ICDO3:8015/3 | Glassy cell carcinoma |
| ICDO3:8020/3 | Carcinoma, undifferentiated, NOS |
| ICDO3:8021/3 | Carcinoma, anaplastic, NOS |
| ICDO3:8022/3 | Pleomorphic carcinoma |
| ICDO3:8030/3 | Giant cell and spindle cell carcinoma |
| ICDO3:8031/3 | Giant cell carcinoma |
| ICDO3:8032/3 | Spindle cell carcinoma, NOS |
| ICDO3:8033/3 | Pseudosarcomatous carcinoma |
| ICDO3:8034/3 | Polygonal cell carcinoma |
| ICDO3:8035/3 | Carcinoma with osteoclast-like giant cells |
| ICDO3:8040/0 | Tumorlet, benign |
| ICDO3:8040/1 | Tumorlet, NOS |
| ICDO3:8041/3 | Small cell carcinoma, NOS |
| ICDO3:8042/3 | Oat cell carcinoma |
| ICDO3:8043/3 | Small cell carcinoma, fusiform cell |
| ICDO3:8044/3 | Small cell carcinoma, intermediate cell |
| ICDO3:8045/3 | Combined small cell carcinoma |
| ICDO3:8046/3 | Non-small cell carcinoma |
| ICDO3:8050/0 | Papilloma, NOS |
| ICDO3:8050/2 | Papillary carcinoma in situ |
| ICDO3:8050/3 | Papillary carcinoma, NOS |
| ICDO3:8051/0 | Verrucous papilloma |
| ICDO3:8051/3 | Verrucous carcinoma, NOS |
| ICDO3:8052/0 | Squamous cell papilloma, NOS |
| ICDO3:8052/2 | Papillary squamous cell carcinoma, non-invasive |
| ICDO3:8052/3 | Papillary squamous cell carcinoma |
| ICDO3:8053/0 | Squamous cell papilloma, inverted |
| ICDO3:8060/0 | Squamous papillomatosis |
| ICDO3:8070/2 | Squamous cell carcinoma in situ, NOS |
| ICDO3:8070/3 | Squamous cell carcinoma, NOS |
| ICDO3:8070/6 | Squamous cell carcinoma, metastatic, NOS |
| ICDO3:8071/3 | Squamous cell carcinoma, keratinizing, NOS |
| ICDO3:8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS |
| ICDO3:8073/3 | Squamous cell carcinoma, small cell, nonkeratinizing |
| ICDO3:8074/3 | Squamous cell carcinoma, spindle cell |
| ICDO3:8075/3 | Squamous cell carcinoma, adenoid |
| ICDO3:8076/2 | Squamous cell carcinoma in situ with questionable stromal invasion |
| ICDO3:8076/3 | Squamous cell carcinoma, microinvasive |
| ICDO3:8077/2 | Squamous intraepithelial neoplasia, grade III |
| ICDO3:8078/3 | Squamous cell carcinoma with horn formation |
| ICDO3:8080/2 | Queyrat erythroplasia |
| ICDO3:8081/2 | Bowen disease |
| ICDO3:8082/3 | Lymphoepithelial carcinoma |
| ICDO3:8083/3 | Basaloid squamous cell carcinoma |
| ICDO3:8084/3 | Squamous cell carcinoma, clear cell type |
| ICDO3:8090/1 | Basal cell tumor |
| ICDO3:8090/3 | Basal cell carcinoma, NOS |
| ICDO3:8091/3 | Multifocal superficial basal cell carcinoma |
| ICDO3:8092/3 | Infiltrating basal cell carcinoma, NOS |
| ICDO3:8093/3 | Basal cell carcinoma, fibroepithelial |
| ICDO3:8094/3 | Basosquamous carcinoma |
| ICDO3:8095/3 | Metatypical carcinoma |
| ICDO3:8096/0 | Intraepidermal epithelioma of Jadassohn |
| ICDO3:8097/3 | Basal cell carcinoma, nodular |
| ICDO3:8098/3 | Adenoid basal carcinoma |
| ICDO3:8100/0 | Trichoepithelioma |
| ICDO3:8101/0 | Trichofolliculoma |
| ICDO3:8102/0 | Trichilemmoma |
| ICDO3:8102/3 | Trichilemmocarcinoma |
| ICDO3:8103/0 | Pilar tumor |
| ICDO3:8110/0 | Pilomatrixoma, NOS |
| ICDO3:8110/3 | Pilomatrix carcinoma |
| ICDO3:8120/0 | Transitional cell papilloma, benign |
| ICDO3:8120/1 | Urothelial papilloma, NOS |
| ICDO3:8120/2 | Transitional cell carcinoma in situ |
| ICDO3:8120/3 | Transitional cell carcinoma, NOS |
| ICDO3:8121/0 | Schneiderian papilloma, NOS |
| ICDO3:8121/1 | Transitional cell papilloma, inverted, NOS |
| ICDO3:8121/3 | Schneiderian carcinoma |
| ICDO3:8122/3 | Transitional cell carcinoma, spindle cell |
| ICDO3:8123/3 | Basaloid carcinoma |
| ICDO3:8124/3 | Cloacogenic carcinoma |
| ICDO3:8130/1 | Papillary transitional cell neoplasm of low malignant potential |
| ICDO3:8130/2 | Papillary transitional cell carcinoma, non-invasive |
| ICDO3:8130/3 | Papillary transitional cell carcinoma |
| ICDO3:8131/3 | Transitional cell carcinoma, micropapillary |
| ICDO3:8140/0 | Adenoma, NOS |
| ICDO3:8140/1 | Atypical adenoma |
| ICDO3:8140/2 | Adenocarcinoma in situ, NOS |
| ICDO3:8140/3 | Adenocarcinoma, NOS |
| ICDO3:8140/6 | Adenocarcinoma, metastatic, NOS |
| ICDO3:8141/3 | Scirrhous adenocarcinoma |
| ICDO3:8142/3 | Linitis plastica |
| ICDO3:8143/3 | Superficial spreading adenocarcinoma |
| ICDO3:8144/3 | Adenocarcinoma, intestinal type |
| ICDO3:8145/3 | Carcinoma, diffuse type |
| ICDO3:8146/0 | Monomorphic adenoma |
| ICDO3:8147/0 | Basal cell adenoma |
| ICDO3:8147/3 | Basal cell adenocarcinoma |
| ICDO3:8148/2 | Glandular intraepithelial neoplasia, grade III |
| ICDO3:8149/0 | Canalicular adenoma |
| ICDO3:8150/0 | Islet cell adenoma |
| ICDO3:8150/1 | Islet cell tumor, NOS |
| ICDO3:8150/3 | Islet cell carcinoma |
| ICDO3:8151/0 | Insulinoma, NOS |
| ICDO3:8151/3 | Insulinoma, malignant |
| ICDO3:8152/1 | Glucagonoma, NOS |
| ICDO3:8152/3 | Glucagonoma, malignant |
| ICDO3:8153/1 | Gastrinoma, NOS |
| ICDO3:8153/3 | Gastrinoma, malignant |
| ICDO3:8154/3 | Mixed islet cell and exocrine adenocarcinoma |
| ICDO3:8155/1 | Vipoma, NOS |
| ICDO3:8155/3 | Vipoma, malignant |
| ICDO3:8156/1 | Somatostatinoma, NOS |
| ICDO3:8156/3 | Somatostatinoma, malignant |
| ICDO3:8157/1 | Enteroglucagonoma, NOS |
| ICDO3:8157/3 | Enteroglucagonoma, malignant |
| ICDO3:8160/0 | Bile duct adenoma |
| ICDO3:8160/3 | Cholangiocarcinoma |
| ICDO3:8161/0 | Bile duct cystadenoma |
| ICDO3:8161/3 | Bile duct cystadenocarcinoma |
| ICDO3:8162/3 | Klatskin tumor |
| ICDO3:8170/0 | Liver cell adenoma |
| ICDO3:8170/3 | Hepatocellular carcinoma, NOS |
| ICDO3:8171/3 | Hepatocellular carcinoma, fibrolamellar |
| ICDO3:8172/3 | Hepatocellular carcinoma, scirrhous |
| ICDO3:8173/3 | Hepatocellular carcinoma, spindle cell variant |
| ICDO3:8174/3 | Hepatocellular carcinoma, clear cell type |
| ICDO3:8175/3 | Hepatocellular carcinoma, pleomorphic type |
| ICDO3:8180/3 | Combined hepatocellular carcinoma and cholangiocarcinoma |
| ICDO3:8190/0 | Trabecular adenoma |
| ICDO3:8190/3 | Trabecular adenocarcinoma |
| ICDO3:8191/0 | Embryonal adenoma |
| ICDO3:8200/0 | Eccrine dermal cylindroma |
| ICDO3:8200/3 | Adenoid cystic carcinoma |
| ICDO3:8201/2 | Cribriform carcinoma in situ |
| ICDO3:8201/3 | Cribriform carcinoma, NOS |
| ICDO3:8202/0 | Microcystic adenoma |
| ICDO3:8204/0 | Lactating adenoma |
| ICDO3:8210/0 | Adenomatous polyp, NOS |
| ICDO3:8210/2 | Adenocarcinoma in situ in adenomatous polyp |
| ICDO3:8210/3 | Adenocarcinoma in adenomatous polyp |
| ICDO3:8211/0 | Tubular adenoma, NOS |
| ICDO3:8211/3 | Tubular adenocarcinoma |
| ICDO3:8212/0 | Flat adenoma |
| ICDO3:8213/0 | Serrated adenoma |
| ICDO3:8214/3 | Parietal cell carcinoma |
| ICDO3:8215/3 | Adenocarcinoma of anal glands |
| ICDO3:8220/0 | Adenomatous polyposis coli |
| ICDO3:8220/3 | Adenocarcinoma in adenomatous polyposis coli |
| ICDO3:8221/0 | Multiple adenomatous polyps |
| ICDO3:8221/3 | Adenocarcinoma in multiple adenomatous polyps |
| ICDO3:8230/2 | Ductal carcinoma in situ, solid type |
| ICDO3:8230/3 | Solid carcinoma, NOS |
| ICDO3:8231/3 | Carcinoma simplex |
| ICDO3:8240/1 | Carcinoid tumor of uncertain malignant potential |
| ICDO3:8240/3 | Carcinoid tumor, NOS |
| ICDO3:8241/3 | Enterochromaffin cell carcinoid |
| ICDO3:8242/1 | Enterochromaffin-like cell carcinoid, NOS |
| ICDO3:8242/3 | Enterochromaffin-like cell tumor, malignant |
| ICDO3:8243/3 | Goblet cell carcinoid |
| ICDO3:8244/3 | Composite carcinoid |
| ICDO3:8245/1 | Tubular carcinoid |
| ICDO3:8245/3 | Adenocarcinoid tumor |
| ICDO3:8246/3 | Neuroendocrine carcinoma, NOS |
| ICDO3:8247/3 | Merkel cell carcinoma |
| ICDO3:8248/1 | Apudoma |
| ICDO3:8249/3 | Atypical carcinoid tumor |
| ICDO3:8250/1 | Pulmonary adenomatosis |
| ICDO3:8250/3 | Bronchiolo-alveolar adenocarcinoma, NOS |
| ICDO3:8251/0 | Alveolar adenoma |
| ICDO3:8251/3 | Alveolar adenocarcinoma |
| ICDO3:8252/3 | Bronchiolo-alveolar carcinoma, non- mucinous |
| ICDO3:8253/3 | Bronchiolo-alveolar carcinoma, mucinous |
| ICDO3:8254/3 | Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous |
| ICDO3:8255/3 | Adenocarcinoma with mixed subtypes |
| ICDO3:8260/0 | Papillary adenoma, NOS |
| ICDO3:8260/3 | Papillary adenocarcinoma, NOS |
| ICDO3:8261/0 | Villous adenoma, NOS |
| ICDO3:8261/2 | Adenocarcinoma in situ in villous adenoma |
| ICDO3:8261/3 | Adenocarcinoma in villous adenoma |
| ICDO3:8262/3 | Villous adenocarcinoma |
| ICDO3:8263/0 | Tubulovillous adenoma, NOS |
| ICDO3:8263/2 | Adenocarcinoma in situ in tubulovillous adenoma |
| ICDO3:8263/3 | Adenocarcinoma in tubulovillous adenoma |
| ICDO3:8264/0 | Papillomatosis, glandular |
| ICDO3:8270/0 | Chromophobe adenoma |
| ICDO3:8270/3 | Chromophobe carcinoma |
| ICDO3:8271/0 | Prolactinoma |
| ICDO3:8272/0 | Pituitary adenoma, NOS |
| ICDO3:8272/3 | Pituitary carcinoma, NOS |
| ICDO3:8280/0 | Acidophil adenoma |
| ICDO3:8280/3 | Acidophil carcinoma |
| ICDO3:8281/0 | Mixed acidophil-basophil adenoma |
| ICDO3:8281/3 | Mixed acidophil-basophil carcinoma |
| ICDO3:8290/0 | Oxyphilic adenoma |
| ICDO3:8290/3 | Oxyphilic adenocarcinoma |
| ICDO3:8300/0 | Basophil adenoma |
| ICDO3:8300/3 | Basophil carcinoma |
| ICDO3:8310/0 | Clear cell adenoma |
| ICDO3:8310/3 | Clear cell adenocarcinoma, NOS |
| ICDO3:8311/1 | Hypernephroid tumor |
| ICDO3:8312/3 | Renal cell carcinoma, NOS |
| ICDO3:8313/0 | Clear cell adenofibroma |
| ICDO3:8313/1 | Clear cell adenofibroma of borderline malignancy |
| ICDO3:8313/3 | Clear cell adenocarcinofibroma |
| ICDO3:8314/3 | Lipid-rich carcinoma |
| ICDO3:8315/3 | Glycogen-rich carcinoma |
| ICDO3:8316/3 | Cyst-associated renal cell carcinoma |
| ICDO3:8317/3 | Renal cell carcinoma, chromophobe type |
| ICDO3:8318/3 | Renal cell carcinoma, sarcomatoid |
| ICDO3:8319/3 | Collecting duct carcinoma |
| ICDO3:8320/3 | Granular cell carcinoma |
| ICDO3:8321/0 | Chief cell adenoma |
| ICDO3:8322/0 | Water-clear cell adenoma |
| ICDO3:8322/3 | Water-clear cell adenocarcinoma |
| ICDO3:8323/0 | Mixed cell adenoma |
| ICDO3:8323/3 | Mixed cell adenocarcinoma |
| ICDO3:8324/0 | Lipoadenoma |
| ICDO3:8325/0 | Metanephric adenoma |
| ICDO3:8330/0 | Follicular adenoma |
| ICDO3:8330/1 | Atypical follicular adenoma |
| ICDO3:8330/3 | Follicular adenocarcinoma, NOS |
| ICDO3:8331/3 | Follicular adenocarcinoma, well differentiated |
| ICDO3:8332/3 | Follicular adenocarcinoma, trabecular |
| ICDO3:8333/0 | Microfollicular adenoma, NOS |
| ICDO3:8333/3 | Fetal adenocarcinoma |
| ICDO3:8334/0 | Macrofollicular adenoma |
| ICDO3:8335/3 | Follicular carcinoma, minimally invasive |
| ICDO3:8336/0 | Hyalinizing trabecular adenoma |
| ICDO3:8337/3 | Insular carcinoma |
| ICDO3:8340/3 | Papillary carcinoma, follicular variant |
| ICDO3:8341/3 | Papillary microcarcinoma |
| ICDO3:8342/3 | Papillary carcinoma, oxyphilic cell |
| ICDO3:8343/3 | Papillary carcinoma, encapsulated |
| ICDO3:8344/3 | Papillary carcinoma, columnar cell |
| ICDO3:8345/3 | Medullary carcinoma with amyloid stroma |
| ICDO3:8346/3 | Mixed medullary-follicular carcinoma |
| ICDO3:8347/3 | Mixed medullary-papillary carcinoma |
| ICDO3:8350/3 | Nonencapsulated sclerosing carcinoma |
| ICDO3:8360/1 | Multiple endocrine adenomas |
| ICDO3:8361/0 | Juxtaglomerular tumor |
| ICDO3:8370/0 | Adrenal cortical adenoma, NOS |
| ICDO3:8370/3 | Adrenal cortical carcinoma |
| ICDO3:8371/0 | Adrenal cortical adenoma, compact cell |
| ICDO3:8372/0 | Adrenal cortical adenoma, pigmented |
| ICDO3:8373/0 | Adrenal cortical adenoma, clear cell |
| ICDO3:8374/0 | Adrenal cortical adenoma, glomerulosa cell |
| ICDO3:8375/0 | Adrenal cortical adenoma, mixed cell |
| ICDO3:8380/0 | Endometrioid adenoma, NOS |
| ICDO3:8380/1 | Endometrioid adenoma, borderline malignancy |
| ICDO3:8380/3 | Endometrioid adenocarcinoma, NOS |
| ICDO3:8381/0 | Endometrioid adenofibroma, NOS |
| ICDO3:8381/1 | Endometrioid adenofibroma, borderline malignancy |
| ICDO3:8381/3 | Endometrioid adenofibroma, malignant |
| ICDO3:8382/3 | Endometrioid adenocarcinoma, secretory variant |
| ICDO3:8383/3 | Endometrioid adenocarcinoma, ciliated cell variant |
| ICDO3:8384/3 | Adenocarcinoma, endocervical type |
| ICDO3:8390/0 | Skin appendage adenoma |
| ICDO3:8390/3 | Skin appendage carcinoma |
| ICDO3:8391/0 | Follicular fibroma |
| ICDO3:8392/0 | Syringofibroadenoma |
| ICDO3:8400/0 | Sweat gland adenoma |
| ICDO3:8400/1 | Sweat gland tumor, NOS |
| ICDO3:8400/3 | Sweat gland adenocarcinoma |
| ICDO3:8401/0 | Apocrine adenoma |
| ICDO3:8401/3 | Apocrine adenocarcinoma |
| ICDO3:8402/0 | Nodular hidradenoma |
| ICDO3:8402/3 | Nodular hidradenoma, malignant |
| ICDO3:8403/0 | Eccrine spiradenoma |
| ICDO3:8403/3 | Malignant eccrine spiradenoma |
| ICDO3:8404/0 | Hidrocystoma |
| ICDO3:8405/0 | Papillary hidradenoma |
| ICDO3:8406/0 | Papillary syringadenoma |
| ICDO3:8407/0 | Syringoma, NOS |
| ICDO3:8407/3 | Sclerosing sweat duct carcinoma |
| ICDO3:8408/0 | Eccrine papillary adenoma |
| ICDO3:8408/1 | Aggressive digital papillary adenoma |
| ICDO3:8408/3 | Eccrine papillary adenocarcinoma |
| ICDO3:8409/0 | Eccrine poroma |
| ICDO3:8409/3 | Eccrine poroma, malignant |
| ICDO3:8410/0 | Sebaceous adenoma |
| ICDO3:8410/3 | Sebaceous adenocarcinoma |
| ICDO3:8413/3 | Eccrine adenocarcinoma |
| ICDO3:8420/0 | Ceruminous adenoma |
| ICDO3:8420/3 | Ceruminous adenocarcinoma |
| ICDO3:8430/1 | Mucoepidermoid tumor |
| ICDO3:8430/3 | Mucoepidermoid carcinoma |
| ICDO3:8440/0 | Cystadenoma, NOS |
| ICDO3:8440/3 | Cystadenocarcinoma, NOS |
| ICDO3:8441/0 | Serous cystadenoma, NOS |
| ICDO3:8441/3 | Serous cystadenocarcinoma, NOS |
| ICDO3:8442/1 | Serous cystadenoma, borderline malignancy |
| ICDO3:8443/0 | Clear cell cystadenoma |
| ICDO3:8444/1 | Clear cell cystic tumor of borderline malignancy |
| ICDO3:8450/0 | Papillary cystadenoma, NOS |
| ICDO3:8450/3 | Papillary cystadenocarcinoma, NOS |
| ICDO3:8451/1 | Papillary cystadenoma, borderline malignancy |
| ICDO3:8452/1 | Solid pseudopapillary tumor |
| ICDO3:8452/3 | Solid pseudopapillary carcinoma |
| ICDO3:8453/0 | Intraductal papillary-mucinous adenoma |
| ICDO3:8453/1 | Intraductal papillary-mucinous tumor with moderate dysplasia |
| ICDO3:8453/2 | Intraductal papillary-mucinous carcinoma, non-invasive |
| ICDO3:8453/3 | Intraductal papillary-mucinous carcinoma, invasive |
| ICDO3:8454/0 | Cystic tumor of atrio-ventricular node |
| ICDO3:8460/0 | Papillary serous cystadenoma, NOS |
| ICDO3:8460/3 | Papillary serous cystadenocarcinoma |
| ICDO3:8461/0 | Serous surface papilloma |
| ICDO3:8461/3 | Serous surface papillary carcinoma |
| ICDO3:8462/1 | Serous papillary cystic tumor of borderline malignancy |
| ICDO3:8463/1 | Serous surface papillary tumor of borderline malignancy |
| ICDO3:8470/0 | Mucinous cystadenoma, NOS |
| ICDO3:8470/1 | Mucinous cystic tumor with moderate dysplasia |
| ICDO3:8470/2 | Mucinous cystadenocarcinoma, non-invasive |
| ICDO3:8470/3 | Mucinous cystadenocarcinoma, NOS |
| ICDO3:8471/0 | Papillary mucinous cystadenoma, NOS |
| ICDO3:8471/3 | Papillary mucinous cystadenocarcinoma |
| ICDO3:8472/1 | Mucinous cystic tumor of borderline malignancy |
| ICDO3:8473/1 | Papillary mucinous cystadenoma, borderline malignancy |
| ICDO3:8480/0 | Mucinous adenoma |
| ICDO3:8480/3 | Mucinous adenocarcinoma |
| ICDO3:8480/6 | Pseudomyxoma peritonei |
| ICDO3:8481/3 | Mucin-producing adenocarcinoma |
| ICDO3:8482/3 | Mucinous adenocarcinoma, endocervical type |
| ICDO3:8490/3 | Signet ring cell carcinoma |
| ICDO3:8490/6 | Metastatic signet ring cell carcinoma |
| ICDO3:8500/2 | Intraductal carcinoma, noninfiltrating, NOS |
| ICDO3:8500/3 | Infiltrating duct carcinoma, NOS |
| ICDO3:8501/2 | Comedocarcinoma, noninfiltrating |
| ICDO3:8501/3 | Comedocarcinoma, NOS |
| ICDO3:8502/3 | Secretory carcinoma of breast |
| ICDO3:8503/0 | Intraductal papilloma |
| ICDO3:8503/2 | Noninfiltrating intraductal papillary adenocarcinoma |
| ICDO3:8503/3 | Intraductal papillary adenocarcinoma with invasion |
| ICDO3:8504/0 | Intracystic papillary adenoma |
| ICDO3:8504/2 | Noninfiltrating intracystic carcinoma |
| ICDO3:8504/3 | Intracystic carcinoma, NOS |
| ICDO3:8505/0 | Intraductal papillomatosis, NOS |
| ICDO3:8506/0 | Adenoma of nipple |
| ICDO3:8507/2 | Intraductal micropapillary carcinoma |
| ICDO3:8508/3 | Cystic hypersecretory carcinoma |
| ICDO3:8510/3 | Medullary carcinoma, NOS |
| ICDO3:8512/3 | Medullary carcinoma with lymphoid stroma |
| ICDO3:8513/3 | Atypical medullary carcinoma |
| ICDO3:8514/3 | Duct carcinoma, desmoplastic type |
| ICDO3:8520/2 | Lobular carcinoma in situ, NOS |
| ICDO3:8520/3 | Lobular carcinoma, NOS |
| ICDO3:8851/0 | Fibrolipoma |
| ICDO3:8851/3 | Liposarcoma, well differentiated |
| ICDO3:8852/0 | Fibromyxolipoma |
| ICDO3:8852/3 | Myxoid liposarcoma |
| ICDO3:8853/3 | Round cell liposarcoma |
| ICDO3:8854/0 | Pleomorphic lipoma |
| ICDO3:8854/3 | Pleomorphic liposarcoma |
| ICDO3:8855/3 | Mixed liposarcoma |
| ICDO3:8856/0 | Intramuscular lipoma |
| ICDO3:8857/0 | Spindle cell lipoma |
| ICDO3:8857/3 | Fibroblastic liposarcoma |
| ICDO3:8858/3 | Dedifferentiated liposarcoma |
| ICDO3:8860/0 | Angiomyolipoma |
| ICDO3:8861/0 | Angiolipoma, NOS |
| ICDO3:8862/0 | Chondroid lipoma |
| ICDO3:8870/0 | Myelolipoma |
| ICDO3:8880/0 | Hibernoma |
| ICDO3:8881/0 | Lipoblastomatosis |
| ICDO3:8890/0 | Leiomyoma, NOS |
| ICDO3:8890/1 | Leiomyomatosis, NOS |
| ICDO3:8890/3 | Leiomyosarcoma, NOS |
| ICDO3:8891/0 | Epithelioid leiomyoma |
| ICDO3:8891/3 | Epithelioid leiomyosarcoma |
| ICDO3:8892/0 | Cellular leiomyoma |
| ICDO3:8893/0 | Bizarre leiomyoma |
| ICDO3:8894/0 | Angiomyoma |
| ICDO3:8894/3 | Angiomyosarcoma |
| ICDO3:8895/0 | Myoma |
| ICDO3:8895/3 | Myosarcoma |
| ICDO3:8896/3 | Myxoid leiomyosarcoma |
| ICDO3:8897/1 | Smooth muscle tumor of uncertain malignant potential |
| ICDO3:8898/1 | Metastasizing leiomyoma |
| ICDO3:8900/0 | Rhabdomyoma, NOS |
| ICDO3:8900/3 | Rhabdomyosarcoma, NOS |
| ICDO3:8901/3 | Pleomorphic rhabdomyosarcoma, adult type |
| ICDO3:8902/3 | Mixed type rhabdomyosarcoma |
| ICDO3:8903/0 | Fetal rhabdomyoma |
| ICDO3:8904/0 | Adult rhabdomyoma |
| ICDO3:8905/0 | Genital rhabdomyoma |
| ICDO3:8910/3 | Embryonal rhabdomyosarcoma, NOS |
| ICDO3:8912/3 | Spindle cell rhabdomyosarcoma |
| ICDO3:8920/3 | Alveolar rhabdomyosarcoma |
| ICDO3:8921/3 | Rhabdomyosarcoma with ganglionic differentiation |
| ICDO3:8930/0 | Endometrial stromal nodule |
| ICDO3:8930/3 | Endometrial stromal sarcoma, NOS |
| ICDO3:8931/3 | Endometrial stromal sarcoma, low grade |
| ICDO3:8932/0 | Adenomyoma |
| ICDO3:8933/3 | Adenosarcoma |
| ICDO3:8934/3 | Carcinofibroma |
| ICDO3:8935/0 | Stromal tumor, benign |
| ICDO3:8935/1 | Stromal tumor, NOS |
| ICDO3:8935/3 | Stromal sarcoma, NOS |
| ICDO3:9300/0 | Adenomatoid odontogenic tumor |
| ICDO3:9301/0 | Calcifying odontogenic cyst |
| ICDO3:9302/0 | Odontogenic ghost cell tumor |
| ICDO3:9310/0 | Ameloblastoma, NOS |
| ICDO3:9310/3 | Ameloblastoma, malignant |
| ICDO3:9311/0 | Odontoameloblastoma |
| ICDO3:9312/0 | Squamous odontogenic tumor |
| ICDO3:9320/0 | Odontogenic myxoma |
| ICDO3:9321/0 | Central odontogenic fibroma |
| ICDO3:9322/0 | Peripheral odontogenic fibroma |
| ICDO3:9330/0 | Ameloblastic fibroma |
| ICDO3:9330/3 | Ameloblastic fibrosarcoma |
| ICDO3:9340/0 | Calcifying epithelial odontogenic tumor |
| ICDO3:9341/1 | Clear cell odontogenic tumor |
| ICDO3:9342/3 | Odontogenic carcinosarcoma |
| ICDO3:9350/1 | Craniopharyngioma |
| ICDO3:9351/1 | Craniopharyngioma, adamantinomatous |
| ICDO3:9352/1 | Craniopharyngioma, papillary |
| ICDO3:9360/1 | Pinealoma |
| ICDO3:9361/1 | Pineocytoma |
| ICDO3:9362/3 | Pineoblastoma |
| ICDO3:9363/0 | Melanotic neuroectodermal tumor |
| ICDO3:9364/3 | Peripheral neuroectodermal tumor |
| ICDO3:9365/3 | Askin tumor |
| ICDO3:9370/3 | Chordoma, NOS |
| ICDO3:9371/3 | Chondroid chordoma |
| ICDO3:9372/3 | Dedifferentiated chordoma |
| ICDO3:9373/0 | Parachordoma |
| ICDO3:9380/3 | Glioma, malignant |
| ICDO3:9381/3 | Gliomatosis cerebri |
| ICDO3:9382/3 | Mixed glioma |
| ICDO3:9383/1 | Subependymoma |
| ICDO3:9384/1 | Subependymal giant cell astrocytoma |
| ICDO3:9390/0 | Choroid plexus papilloma, NOS |
| ICDO3:9390/1 | Atypical choroid plexus papilloma |
| ICDO3:9390/3 | Choroid plexus carcinoma |
| ICDO3:9391/3 | Ependymoma, NOS |
| ICDO3:8521/3 | Infiltrating ductular carcinoma |
| ICDO3:8522/2 | Intraductal carcinoma and lobular carcinoma in situ |
| ICDO3:8522/3 | Infiltrating duct and lobular carcinoma |
| ICDO3:8523/3 | Infiltrating duct mixed with other types of carcinoma |
| ICDO3:8524/3 | Infiltrating lobular mixed with other types of carcinoma |
| ICDO3:8525/3 | Polymorphous low grade adenocarcinoma |
| ICDO3:8530/3 | Inflammatory carcinoma |
| ICDO3:8540/3 | Paget disease, mammary |
| ICDO3:8541/3 | Paget disease and infiltrating duct carcinoma of breast |
| ICDO3:8542/3 | Paget disease, extramammary |
| ICDO3:8543/3 | Paget disease and intraductal carcinoma of breast |
| ICDO3:8550/0 | Acinar cell adenoma |
| ICDO3:8550/1 | Acinar cell tumor |
| ICDO3:8550/3 | Acinar cell carcinoma |
| ICDO3:8551/3 | Acinar cell cystadenocarcinoma |
| ICDO3:8560/0 | Mixed squamous cell and glandular papilloma |
| ICDO3:8560/3 | Adenosquamous carcinoma |
| ICDO3:8561/0 | Adenolymphoma |
| ICDO3:8562/3 | Epithelial-myoepithelial carcinoma |
| ICDO3:8570/3 | Adenocarcinoma with squamous metaplasia |
| ICDO3:8571/3 | Adenocarcinoma with cartilaginous and osseous metaplasia |
| ICDO3:8572/3 | Adenocarcinoma with spindle cell metaplasia |
| ICDO3:8573/3 | Adenocarcinoma with apocrine metaplasia |
| ICDO3:8574/3 | Adenocarcinoma with neuroendocrine differentiation |
| ICDO3:8575/3 | Metaplastic carcinoma, NOS |
| ICDO3:8576/3 | Hepatoid adenocarcinoma |
| ICDO3:8580/0 | Thymoma, benign |
| ICDO3:8580/1 | Thymoma, NOS |
| ICDO3:8580/3 | Thymoma, malignant, NOS |
| ICDO3:8581/1 | Thymoma, type A, NOS |
| ICDO3:8581/3 | Thymoma, type A, malignant |
| ICDO3:8582/1 | Thymoma, type AB, NOS |
| ICDO3:8582/3 | Thymoma, type AB, malignant |
| ICDO3:8583/1 | Thymoma, type B1, NOS |
| ICDO3:8583/3 | Thymoma, type B1, malignant |
| ICDO3:8584/1 | Thymoma, type B2, NOS |
| ICDO3:8584/3 | Thymoma, type B2, malignant |
| ICDO3:8585/1 | Thymoma, type B3, NOS |
| ICDO3:8585/3 | Thymoma, type B3, malignant |
| ICDO3:8586/3 | Thymic carcinoma, NOS |
| ICDO3:8587/0 | Ectopic hamartomatous thymoma |
| ICDO3:8588/3 | Spindle epithelial tumor with thymus-like element |
| ICDO3:8589/3 | Carcinoma showing thymus-like element |
| ICDO3:8590/1 | Sex cord-gonadal stromal tumor, NOS |
| ICDO3:8591/1 | Sex cord-gonadal stromal tumor, incompletely differentiated |
| ICDO3:8592/1 | Sex cord-gonadal stromal tumor, mixed forms |
| ICDO3:8593/1 | Stromal tumor with minor sex cord elements |
| ICDO3:8600/0 | Thecoma, NOS |
| ICDO3:8600/3 | Thecoma, malignant |
| ICDO3:8601/0 | Thecoma, luteinized |
| ICDO3:8602/0 | Sclerosing stromal tumor |
| ICDO3:8610/0 | Luteoma, NOS |
| ICDO3:8620/1 | Granulosa cell tumor, adult type |
| ICDO3:8620/3 | Granulosa cell tumor, malignant |
| ICDO3:8621/1 | Granulosa cell-theca cell tumor |
| ICDO3:8622/1 | Granulosa cell tumor, juvenile |
| ICDO3:8623/1 | Sex cord tumor with annular tubules |
| ICDO3:8630/0 | Androblastoma, benign |
| ICDO3:8630/1 | Androblastoma, NOS |
| ICDO3:8630/3 | Androblastoma, malignant |
| ICDO3:8631/0 | Sertoli-Leydig cell tumor, well differentiated |
| ICDO3:8631/1 | Sertoli-Leydig cell tumor of intermediate differentiation |
| ICDO3:8631/3 | Sertoli-Leydig cell tumor, poorly differentiated |
| ICDO3:8632/1 | Gynandroblastoma |
| ICDO3:8633/1 | Sertoli-Leydig cell tumor, retiform |
| ICDO3:8634/1 | Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements |
| ICDO3:8634/3 | Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements |
| ICDO3:8640/1 | Sertoli cell tumor, NOS |
| ICDO3:8640/3 | Sertoli cell carcinoma |
| ICDO3:8641/0 | Sertoli cell tumor with lipid storage |
| ICDO3:8642/1 | Large cell calcifying Sertoli cell tumor |
| ICDO3:8650/0 | Leydig cell tumor, benign |
| ICDO3:8650/1 | Leydig cell tumor, NOS |
| ICDO3:8650/3 | Leydig cell tumor, malignant |
| ICDO3:8660/0 | Hilus cell tumor |
| ICDO3:8670/0 | Lipid cell tumor of ovary |
| ICDO3:8670/3 | Steroid cell tumor, malignant |
| ICDO3:8671/0 | Adrenal rest tumor |
| ICDO3:8680/0 | Paraganglioma, benign |
| ICDO3:8680/1 | Paraganglioma, NOS |
| ICDO3:8680/3 | Paraganglioma, malignant |
| ICDO3:8681/1 | Sympathetic paraganglioma |
| ICDO3:8682/1 | Parasympathetic paraganglioma |
| ICDO3:8683/0 | Gangliocytic paraganglioma |
| ICDO3:8690/1 | Glomus jugulare tumor, NOS |
| ICDO3:8691/1 | Aortic body tumor |
| ICDO3:8692/1 | Carotid body tumor |
| ICDO3:8693/1 | Extra-adrenal paraganglioma, NOS |
| ICDO3:8693/3 | Extra-adrenal paraganglioma, malignant |
| ICDO3:8700/0 | Pheochromocytoma, NOS |
| ICDO3:8700/3 | Pheochromocytoma, malignant |
| ICDO3:8710/3 | Glomangiosarcoma |
| ICDO3:8711/0 | Glomus tumor, NOS |
| ICDO3:8711/3 | Glomus tumor, malignant |
| ICDO3:8712/0 | Glomangioma |
| ICDO3:8713/0 | Glomangiomyoma |
| ICDO3:8720/0 | Pigmented nevus, NOS |
| ICDO3:8720/2 | Melanoma in situ |
| ICDO3:8720/3 | Malignant melanoma, NOS |
| ICDO3:8721/3 | Nodular melanoma |
| ICDO3:8722/0 | Balloon cell nevus |
| ICDO3:8722/3 | Balloon cell melanoma |
| ICDO3:8723/0 | Halo nevus |
| ICDO3:8723/3 | Malignant melanoma, regressing |
| ICDO3:8725/0 | Neuronevus |
| ICDO3:8726/0 | Magnocellular nevus |
| ICDO3:8727/0 | Dysplastic nevus |
| ICDO3:8728/0 | Diffuse melanocytosis |
| ICDO3:8728/1 | Meningeal melanocytoma |
| ICDO3:8728/3 | Meningeal melanomatosis |
| ICDO3:8730/0 | Nonpigmented nevus |
| ICDO3:8730/3 | Amelanotic melanoma |
| ICDO3:8740/0 | Junctional nevus, NOS |
| ICDO3:8740/3 | Malignant melanoma in junctional nevus |
| ICDO3:8741/2 | Precancerous melanosis, NOS |
| ICDO3:8741/3 | Malignant melanoma in precancerous melanosis |
| ICDO3:8742/2 | Lentigo maligna |
| ICDO3:8742/3 | Lentigo maligna melanoma |
| ICDO3:8743/3 | Superficial spreading melanoma |
| ICDO3:8744/3 | Acral lentiginous melanoma, malignant |
| ICDO3:8745/3 | Desmoplastic melanoma, malignant |
| ICDO3:8746/3 | Mucosal lentiginous melanoma |
| ICDO3:8750/0 | Intradermal nevus |
| ICDO3:8760/0 | Compound nevus |
| ICDO3:8761/0 | Small congenital nevus |
| ICDO3:8761/1 | Giant pigmented nevus, NOS |
| ICDO3:8761/3 | Malignant melanoma in giant pigmented nevus |
| ICDO3:8762/1 | Proliferative dermal lesion in congenital nevus |
| ICDO3:8770/0 | Epithelioid and spindle cell nevus |
| ICDO3:8770/3 | Mixed epithelioid and spindle cell melanoma |
| ICDO3:8771/0 | Epithelioid cell nevus |
| ICDO3:8771/3 | Epithelioid cell melanoma |
| ICDO3:8772/0 | Spindle cell nevus, NOS |
| ICDO3:8772/3 | Spindle cell melanoma, NOS |
| ICDO3:8773/3 | Spindle cell melanoma, type A |
| ICDO3:8774/3 | Spindle cell melanoma, type B |
| ICDO3:8780/0 | Blue nevus, NOS |
| ICDO3:8780/3 | Blue nevus, malignant |
| ICDO3:8790/0 | Cellular blue nevus |
| ICDO3:8800/0 | Soft tissue tumor, benign |
| ICDO3:8800/3 | Sarcoma, NOS |
| ICDO3:8800/9 | Sarcomatosis, NOS |
| ICDO3:8801/3 | Spindle cell sarcoma |
| ICDO3:8802/3 | Giant cell sarcoma |
| ICDO3:8803/3 | Small cell sarcoma |
| ICDO3:8804/3 | Epithelioid sarcoma |
| ICDO3:8805/3 | Undifferentiated sarcoma |
| ICDO3:8806/3 | Desmoplastic small round cell tumor |
| ICDO3:8810/0 | Fibroma, NOS |
| ICDO3:8810/1 | Cellular fibroma |
| ICDO3:8810/3 | Fibrosarcoma, NOS |
| ICDO3:8811/0 | Fibromyxoma |
| ICDO3:8811/3 | Fibromyxosarcoma |
| ICDO3:8812/0 | Periosteal fibroma |
| ICDO3:8812/3 | Periosteal fibrosarcoma |
| ICDO3:8813/0 | Fascial fibroma |
| ICDO3:8813/3 | Fascial fibrosarcoma |
| ICDO3:8814/3 | Infantile fibrosarcoma |
| ICDO3:8815/0 | Solitary fibrous tumor |
| ICDO3:8815/3 | Solitary fibrous tumor, malignant |
| ICDO3:8820/0 | Elastofibroma |
| ICDO3:8821/1 | Aggressive fibromatosis |
| ICDO3:8822/1 | Abdominal fibromatosis |
| ICDO3:8823/0 | Desmoplastic fibroma |
| ICDO3:8824/0 | Myofibroma |
| ICDO3:8824/1 | Myofibromatosis |
| ICDO3:8825/0 | Myofibroblastoma |
| ICDO3:8825/1 | Myofibroblastic tumor, NOS |
| ICDO3:8826/0 | Angiomyofibroblastoma |
| ICDO3:8827/1 | Myofibroblastic tumor, peribronchial |
| ICDO3:8830/0 | Benign fibrous histiocytoma |
| ICDO3:8830/1 | Atypical fibrous histiocytoma |
| ICDO3:8830/3 | Malignant fibrous histiocytoma |
| ICDO3:8831/0 | Histiocytoma, NOS |
| ICDO3:8832/0 | Dermatofibroma, NOS |
| ICDO3:8832/3 | Dermatofibrosarcoma, NOS |
| ICDO3:8833/3 | Pigmented dermatofibrosarcoma protuberans |
| ICDO3:8834/1 | Giant cell fibroblastoma |
| ICDO3:8835/1 | Plexiform fibrohistiocytic tumor |
| ICDO3:8836/1 | Angiomatoid fibrous histiocytoma |
| ICDO3:8840/0 | Myxoma, NOS |
| ICDO3:8840/3 | Myxosarcoma |
| ICDO3:8841/1 | Angiomyxoma |
| ICDO3:8842/0 | Ossifying fibromyxoid tumor |
| ICDO3:8850/0 | Lipoma, NOS |
| ICDO3:8850/1 | Atypical lipoma/j |
| ICDO3:8850/3 | Liposarcoma, NOS |
| ICDO3:8936/0 | Gastrointestinal stromal tumor, benign |
| ICDO3:8936/1 | Gastrointestinal stromal tumor, NOS |
| ICDO3:8936/3 | Gastrointestinal stromal sarcoma |
| ICDO3:8940/0 | Pleomorphic adenoma |
| ICDO3:8940/3 | Mixed tumor, malignant, NOS |
| ICDO3:8941/3 | Carcinoma in pleomorphic adenoma |
| ICDO3:8950/3 | Mullerian mixed tumor |
| ICDO3:8951/3 | Mesodermal mixed tumor |
| ICDO3:8959/0 | Benign cystic nephroma |
| ICDO3:8959/1 | Cystic partially differentiated nephroblastoma |
| ICDO3:8959/3 | Malignant cystic nephroma |
| ICDO3:8960/1 | Mesoblastic nephroma |
| ICDO3:8960/3 | Nephroblastoma, NOS |
| ICDO3:8963/3 | Malignant rhabdoid tumor |
| ICDO3:8964/3 | Clear cell sarcoma of kidney |
| ICDO3:8965/0 | Nephrogenic adenofibroma |
| ICDO3:8966/0 | Renomedullary interstitial cell tumor |
| ICDO3:8967/0 | Ossifying renal tumor |
| ICDO3:8970/3 | Hepatoblastoma |
| ICDO3:8971/3 | Pancreatoblastoma |
| ICDO3:8972/3 | Pulmonary blastoma |
| ICDO3:8973/3 | Pleuropulmonary blastoma |
| ICDO3:8974/1 | Sialoblastoma |
| ICDO3:8980/3 | Carcinosarcoma, NOS |
| ICDO3:8981/3 | Carcinosarcoma, embryonal |
| ICDO3:8982/0 | Myoepithelioma |
| ICDO3:8982/3 | Malignant myoepithelioma |
| ICDO3:8983/0 | Adenomyoepithelioma |
| ICDO3:8990/0 | Mesenchymoma, benign |
| ICDO3:8990/1 | Mesenchymoma, NOS |
| ICDO3:8990/3 | Mesenchymoma, malignant |
| ICDO3:8991/3 | Embryonal sarcoma |
| ICDO3:9000/0 | Brenner tumor, NOS |
| ICDO3:9000/1 | Brenner tumor, borderline malignancy |
| ICDO3:9000/3 | Brenner tumor, malignant |
| ICDO3:9010/0 | Fibroadenoma, NOS |
| ICDO3:9011/0 | Intracanalicular fibroadenoma |
| ICDO3:9012/0 | Pericanalicular fibroadenoma |
| ICDO3:9013/0 | Adenofibroma, NOS |
| ICDO3:9014/0 | Serous adenofibroma, NOS |
| ICDO3:9014/1 | Serous adenofibroma of borderline malignancy |
| ICDO3:9014/3 | Serous adenocarcinofibroma |
| ICDO3:9015/0 | Mucinous adenofibroma, NOS |
| ICDO3:9015/1 | Mucinous adenofibroma of borderline malignancy |
| ICDO3:9015/3 | Mucinous adenocarcinofibroma |
| ICDO3:9016/0 | Giant fibroadenoma |
| ICDO3:9020/0 | Phyllodes tumor, benign |
| ICDO3:9020/1 | Phyllodes tumor, borderline |
| ICDO3:9020/3 | Phyllodes tumor, malignant |
| ICDO3:9030/0 | Juvenile fibroadenoma |
| ICDO3:9040/0 | Synovioma, benign |
| ICDO3:9040/3 | Synovial sarcoma, NOS |
| ICDO3:9041/3 | Synovial sarcoma, spindle cell |
| ICDO3:9042/3 | Synovial sarcoma, epithelioid cell |
| ICDO3:9043/3 | Synovial sarcoma, biphasic |
| ICDO3:9044/3 | Clear cell sarcoma, NOS |
| ICDO3:9050/0 | Mesothelioma, benign |
| ICDO3:9050/3 | Mesothelioma, malignant |
| ICDO3:9051/0 | Fibrous mesothelioma, benign |
| ICDO3:9051/3 | Fibrous mesothelioma, malignant |
| ICDO3:9052/0 | Epithelioid mesothelioma, benign |
| ICDO3:9052/3 | Epithelioid mesothelioma, malignant |
| ICDO3:9053/3 | Mesothelioma, biphasic, malignant |
| ICDO3:9054/0 | Adenomatoid tumor, NOS |
| ICDO3:9055/0 | Multicystic mesothelioma, benign |
| ICDO3:9055/1 | Cystic mesothelioma, NOS |
| ICDO3:9060/3 | Dysgerminoma |
| ICDO3:9061/3 | Seminoma, NOS |
| ICDO3:9062/3 | Seminoma, anaplastic |
| ICDO3:9063/3 | Spermatocytic seminoma |
| ICDO3:9064/2 | Intratubular malignant germ cells |
| ICDO3:9064/3 | Germinoma |
| ICDO3:9065/3 | Germ cell tumor, nonseminomatous |
| ICDO3:9070/3 | Embryonal carcinoma, NOS |
| ICDO3:9071/3 | Yolk sac tumor |
| ICDO3:9072/3 | Polyembryoma |
| ICDO3:9073/1 | Gonadoblastoma |
| ICDO3:9080/0 | Teratoma, benign |
| ICDO3:9080/1 | Teratoma, NOS |
| ICDO3:9080/3 | Teratoma, malignant, NOS |
| ICDO3:9081/3 | Teratocarcinoma |
| ICDO3:9082/3 | Malignant teratoma, undifferentiated |
| ICDO3:9083/3 | Malignant teratoma, intermediate |
| ICDO3:9084/0 | Dermoid cyst, NOS |
| ICDO3:9084/3 | Teratoma with malignant transformation |
| ICDO3:9085/3 | Mixed germ cell tumor |
| ICDO3:9090/0 | Struma ovarii, NOS |
| ICDO3:9090/3 | Struma ovarii, malignant |
| ICDO3:9091/1 | Strumal carcinoid |
| ICDO3:9100/0 | Hydatidiform mole, NOS |
| ICDO3:9100/1 | Invasive hydatidiform mole |
| ICDO3:9100/3 | Choriocarcinoma, NOS |
| ICDO3:9101/3 | Choriocarcinoma combined with other germ cell elements |
| ICDO3:9102/3 | Malignant teratoma, trophoblastic |
| ICDO3:9103/0 | Partial hydatidiform mole |
| ICDO3:9104/1 | Placental site trophoblastic tumor |
| ICDO3:9105/3 | Trophoblastic tumor, epithelioid |
| ICDO3:9110/0 | Mesonephroma, benign |
| ICDO3:9110/1 | Mesonephric tumor, NOS |
| ICDO3:9110/3 | Mesonephroma, malignant |
| ICDO3:9120/0 | Hemangioma, NOS |
| ICDO3:9120/3 | Hemangiosarcoma |
| ICDO3:9121/0 | Cavernous hemangioma |
| ICDO3:9122/0 | Venous hemangioma |
| ICDO3:9123/0 | Racemose hemangioma |
| ICDO3:9124/3 | Kupffer cell sarcoma |
| ICDO3:9125/0 | Epithelioid hemangioma |
| ICDO3:9130/0 | Hemangioendothelioma, benign |
| ICDO3:9130/1 | Hemangioendothelioma, NOS |
| ICDO3:9130/3 | Hemangioendothelioma, malignant |
| ICDO3:9131/0 | Capillary hemangioma |
| ICDO3:9132/0 | Intramuscular hemangioma |
| ICDO3:9133/1 | Epithelioid hemangioendothelioma, NOS |
| ICDO3:9133/3 | Epithelioid hemangioendothelioma, malignant |
| ICDO3:9135/1 | Endovascular papillary angioendothelioma |
| ICDO3:9136/1 | Spindle cell hemangioendothelioma |
| ICDO3:9140/3 | Kaposi sarcoma |
| ICDO3:9141/0 | Angiokeratoma |
| ICDO3:9142/0 | Verrucous keratotic hemangioma |
| ICDO3:9150/0 | Hemangiopericytoma, benign |
| ICDO3:9150/1 | Hemangiopericytoma, NOS |
| ICDO3:9150/3 | Hemangiopericytoma, malignant |
| ICDO3:9160/0 | Angiofibroma, NOS |
| ICDO3:9161/0 | Acquired tufted hemangioma |
| ICDO3:9161/1 | Hemangioblastoma |
| ICDO3:9170/0 | Lymphangioma, NOS |
| ICDO3:9170/3 | Lymphangiosarcoma |
| ICDO3:9171/0 | Capillary lymphangioma |
| ICDO3:9172/0 | Cavernous lymphangioma |
| ICDO3:9173/0 | Cystic lymphangioma |
| ICDO3:9174/0 | Lymphangiomyoma |
| ICDO3:9174/1 | Lymphangiomyomatosis |
| ICDO3:9175/0 | Hemolymphangioma |
| ICDO3:9180/0 | Osteoma, NOS |
| ICDO3:9180/3 | Osteosarcoma, NOS |
| ICDO3:9181/3 | Chondroblastic osteosarcoma |
| ICDO3:9182/3 | Fibroblastic osteosarcoma |
| ICDO3:9183/3 | Telangiectatic osteosarcoma |
| ICDO3:9184/3 | Osteosarcoma in Paget disease of bone |
| ICDO3:9185/3 | Small cell osteosarcoma |
| ICDO3:9186/3 | Central osteosarcoma |
| ICDO3:9187/3 | Intraosseous well differentiated osteosarcoma |
| ICDO3:9191/0 | Osteoid osteoma, NOS |
| ICDO3:9192/3 | Parosteal osteosarcoma |
| ICDO3:9193/3 | Periosteal osteosarcoma |
| ICDO3:9194/3 | High grade surface osteosarcoma |
| ICDO3:9195/3 | Intracortical osteosarcoma |
| ICDO3:9200/0 | Osteoblastoma, NOS |
| ICDO3:9200/1 | Aggressive osteoblastoma |
| ICDO3:9210/0 | Osteochondroma |
| ICDO3:9210/1 | Osteochondromatosis, NOS |
| ICDO3:9220/0 | Chondroma, NOS |
| ICDO3:9220/1 | Chondromatosis, NOS |
| ICDO3:9220/3 | Chondrosarcoma, NOS |
| ICDO3:9221/0 | Juxtacortical chondroma |
| ICDO3:9221/3 | Juxtacortical chondrosarcoma |
| ICDO3:9230/0 | Chondroblastoma, NOS |
| ICDO3:9230/3 | Chondroblastoma, malignant |
| ICDO3:9231/3 | Myxoid chondrosarcoma |
| ICDO3:9240/3 | Mesenchymal chondrosarcoma |
| ICDO3:9241/0 | Chondromyxoid fibroma |
| ICDO3:9242/3 | Clear cell chondrosarcoma |
| ICDO3:9243/3 | Dedifferentiated chondrosarcoma |
| ICDO3:9250/1 | Giant cell tumor of bone, NOS |
| ICDO3:9250/3 | Giant cell tumor of bone, malignant |
| ICDO3:9251/1 | Giant cell tumor of soft parts, NOS |
| ICDO3:9251/3 | Malignant giant cell tumor of soft parts |
| ICDO3:9252/0 | Tenosynovial giant cell tumor |
| ICDO3:9252/3 | Malignant tenosynovial giant cell tumor |
| ICDO3:9260/3 | Ewing sarcoma |
| ICDO3:9261/3 | Adamantinoma of long bones |
| ICDO3:9262/0 | Ossifying fibroma |
| ICDO3:9270/0 | Odontogenic tumor, benign |
| ICDO3:9270/1 | Odontogenic tumor, NOS |
| ICDO3:9270/3 | Odontogenic tumor, malignant |
| ICDO3:9271/0 | Ameloblastic fibrodentinoma |
| ICDO3:9272/0 | Cementoma, NOS |
| ICDO3:9273/0 | Cementoblastoma, benign |
| ICDO3:9274/0 | Cementifying fibroma |
| ICDO3:9275/0 | Gigantiform cementoma |
| ICDO3:9280/0 | Odontoma, NOS |
| ICDO3:9281/0 | Compound odontoma |
| ICDO3:9282/0 | Complex odontoma |
| ICDO3:9290/0 | Ameloblastic fibro-odontoma |
| ICDO3:9290/3 | Ameloblastic odontosarcoma |
| ICDO3:9392/3 | Ependymoma, anaplastic |
| ICDO3:9393/3 | Papillary ependymoma |
| ICDO3:9394/1 | Myxopapillary ependymoma |
| ICDO3:9400/3 | Astrocytoma, NOS |
| ICDO3:9401/3 | Astrocytoma, anaplastic |
| ICDO3:9410/3 | Protoplasmic astrocytoma |
| ICDO3:9411/3 | Gemistocytic astrocytoma |
| ICDO3:9412/1 | Desmoplastic infantile astrocytoma |
| ICDO3:9413/0 | Dysembryoplastic neuroepithelial tumor |
| ICDO3:9420/3 | Fibrillary astrocytoma |
| ICDO3:9421/1 | Pilocytic astrocytoma |
| ICDO3:9423/3 | Polar spongioblastoma |
| ICDO3:9424/3 | Pleomorphic xanthoastrocytoma |
| ICDO3:9430/3 | Astroblastoma |
| ICDO3:9440/3 | Glioblastoma, NOS |
| ICDO3:9441/3 | Giant cell glioblastoma |
| ICDO3:9442/1 | Gliofibroma |
| ICDO3:9442/3 | Gliosarcoma |
| ICDO3:9444/1 | Chordoid glioma |
| ICDO3:9450/3 | Oligodendroglioma, NOS |
| ICDO3:9451/3 | Oligodendroglioma, anaplastic |
| ICDO3:9460/3 | Oligodendroblastoma |
| ICDO3:9470/3 | Medulloblastoma, NOS |
| ICDO3:9471/3 | Desmoplastic nodular medulloblastoma |
| ICDO3:9472/3 | Medullomyoblastoma |
| ICDO3:9473/3 | Primitive neuroectodermal tumor, NOS |
| ICDO3:9474/3 | Large cell medulloblastoma |
| ICDO3:9480/3 | Cerebellar sarcoma, NOS |
| ICDO3:9490/0 | Ganglioneuroma |
| ICDO3:9490/3 | Ganglioneuroblastoma |
| ICDO3:9491/0 | Ganglioneuromatosis |
| ICDO3:9492/0 | Gangliocytoma |
| ICDO3:9493/0 | Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) |
| ICDO3:9500/3 | Neuroblastoma, NOS |
| ICDO3:9501/0 | Medulloepithelioma, benign |
| ICDO3:9501/3 | Medulloepithelioma, NOS |
| ICDO3:9502/0 | Teratoid medulloepithelioma, benign |
| ICDO3:9502/3 | Teratoid medulloepithelioma |
| ICDO3:9503/3 | Neuroepithelioma, NOS |
| ICDO3:9504/3 | Spongioneuroblastoma |
| ICDO3:9505/1 | Ganglioglioma, NOS |
| ICDO3:9505/3 | Ganglioglioma, anaplastic |
| ICDO3:9506/1 | Central neurocytoma |
| ICDO3:9507/0 | Pacinian tumor |
| ICDO3:9508/3 | Atypical teratoid/rhabdoid tumor |
| ICDO3:9510/0 | Retinocytoma |
| ICDO3:9510/3 | Retinoblastoma, NOS |
| ICDO3:9511/3 | Retinoblastoma, differentiated |
| ICDO3:9512/3 | Retinoblastoma, undifferentiated |
| ICDO3:9513/3 | Retinoblastoma, diffuse |
| ICDO3:9514/1 | Retinoblastoma, spontaneously regressed |
| ICDO3:9520/3 | Olfactory neurogenic tumor |
| ICDO3:9521/3 | Olfactory neurocytoma |
| ICDO3:9522/3 | Olfactory neuroblastoma |
| ICDO3:9523/3 | Olfactory neuroepithelioma |
| ICDO3:9530/0 | Meningioma, NOS |
| ICDO3:9530/1 | Meningiomatosis, NOS |
| ICDO3:9530/3 | Meningioma, malignant |
| ICDO3:9531/0 | Meningothelial meningioma |
| ICDO3:9532/0 | Fibrous meningioma |
| ICDO3:9533/0 | Psammomatous meningioma |
| ICDO3:9534/0 | Angiomatous meningioma |
| ICDO3:9535/0 | Hemangioblastic meningioma |
| ICDO3:9537/0 | Transitional meningioma |
| ICDO3:9538/1 | Clear cell meningioma |
| ICDO3:9538/3 | Papillary meningioma |
| ICDO3:9539/1 | Atypical meningioma |
| ICDO3:9539/3 | Meningeal sarcomatosis |
| ICDO3:9540/0 | Neurofibroma, NOS |
| ICDO3:9540/1 | Neurofibromatosis, NOS |
| ICDO3:9540/3 | Malignant peripheral nerve sheath tumor |
| ICDO3:9541/0 | Melanotic neurofibroma |
| ICDO3:9550/0 | Plexiform neurofibroma |
| ICDO3:9560/0 | Neurilemoma, NOS |
| ICDO3:9560/1 | Neurinomatosis |
| ICDO3:9560/3 | Neurilemoma, malignant |
| ICDO3:9561/3 | Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation |
| ICDO3:9562/0 | Neurothekeoma |
| ICDO3:9570/0 | Neuroma, NOS |
| ICDO3:9571/0 | Perineurioma, NOS |
| ICDO3:9571/3 | Perineurioma, malignant |
| ICDO3:9580/0 | Granular cell tumor, NOS |
| ICDO3:9580/3 | Granular cell tumor, malignant |
| ICDO3:9581/3 | Alveolar soft part sarcoma |
| ICDO3:9582/0 | Granular cell tumor of the sellar region |
| ICDO3:9590/3 | Malignant lymphoma, NOS |
| ICDO3:9591/3 | Malignant lymphoma, non-Hodgkin, NOS |
| ICDO3:9596/3 | Composite Hodgkin and non-Hodgkin lymphoma |
| ICDO3:9650/3 | Hodgkin lymphoma, NOS |
| ICDO3:9651/3 | Hodgkin lymphoma, lymphocyte-rich |
| ICDO3:9652/3 | Hodgkin lymphoma, mixed cellularity, NOS |
| ICDO3:9653/3 | Hodgkin lymphoma, lymphocyte depletion, NOS |
| ICDO3:9654/3 | Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis |
| ICDO3:9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular |
| ICDO3:9659/3 | Hodgkin lymphoma, nodular lymphocyte predominance |
| ICDO3:9661/3 | Hodgkin granuloma |
| ICDO3:9662/3 | Hodgkin sarcoma |
| ICDO3:9663/3 | Hodgkin lymphoma, nodular sclerosis, NOS |
| ICDO3:9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase |
| ICDO3:9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1 |
| ICDO3:9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2 |
| ICDO3:9670/3 | Malignant lymphoma, small B lymphocytic, NOS |
| ICDO3:9671/3 | Malignant lymphoma, lymphoplasmacytic |
| ICDO3:9673/3 | Mantle cell lymphoma |
| ICDO3:9675/3 | Malignant lymphoma, mixed small and large cell, diffuse |
| ICDO3:9678/3 | Primary effusion lymphoma |
| ICDO3:9679/3 | Mediastinal large B-cell lymphoma |
| ICDO3:9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS |
| ICDO3:9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS |
| ICDO3:9687/3 | Burkitt lymphoma, NOS |
| ICDO3:9689/3 | Splenic marginal zone B-cell lymphoma |
| ICDO3:9690/3 | Follicular lymphoma, NOS |
| ICDO3:9691/3 | Follicular lymphoma, grade 2 |
| ICDO3:9695/3 | Follicular lymphoma, grade 1 |
| ICDO3:9698/3 | Follicular lymphoma, grade 3 |
| ICDO3:9699/3 | Marginal zone B-cell lymphoma, NOS |
| ICDO3:9700/3 | Mycosis fungoides |
| ICDO3:9701/3 | Sezary syndrome |
| ICDO3:9702/3 | Mature T-cell lymphoma, NOS |
| ICDO3:9705/3 | Angioimmunoblastic T-cell lymphoma |
| ICDO3:9708/3 | Subcutaneous panniculitis-like T-cell lymphoma |
| ICDO3:9709/3 | Cutaneous T-cell lymphoma, NOS |
| ICDO3:9714/3 | Anaplastic large cell lymphoma, T cell and Null cell type |
| ICDO3:9716/3 | Hepatosplenic (gamma-delta) cell lymphoma |
| ICDO3:9717/3 | Intestinal T-cell lymphoma |
| ICDO3:9718/3 | Primary cutaneous CD30+ T-cell lymphoproliferative disorder |
| ICDO3:9719/3 | NK/T-cell lymphoma, nasal and nasal-type |
| ICDO3:9727/3 | Precursor cell lymphoblastic lymphoma, NOS |
| ICDO3:9728/3 | Precursor B-cell lymphoblastic lymphoma |
| ICDO3:9729/3 | Precursor T-cell lymphoblastic lymphoma |
| ICDO3:9731/3 | Plasmacytoma, NOS |
| ICDO3:9732/3 | Multiple myeloma |
| ICDO3:9733/3 | Plasma cell leukemia |
| ICDO3:9734/3 | Plasmacytoma, extramedullary (not occurring in bone) |
| ICDO3:9740/1 | Mastocytoma, NOS |
| ICDO3:9740/3 | Mast cell sarcoma |
| ICDO3:9741/3 | Malignant mastocytosis |
| ICDO3:9742/3 | Mast cell leukemia |
| ICDO3:9750/3 | Malignant histiocytosis |
| ICDO3:9751/1 | Langerhans cell histiocytosis, NOS |
| ICDO3:9752/1 | Langerhans cell histiocytosis, unifocal |
| ICDO3:9753/1 | Langerhans cell histiocytosis, multifocal |
| ICDO3:9754/3 | Langerhans cell histiocytosis, disseminated |
| ICDO3:9755/3 | Histiocytic sarcoma |
| ICDO3:9756/3 | Langerhans cell sarcoma |
| ICDO3:9757/3 | Interdigitating dendritic cell sarcoma |
| ICDO3:9758/3 | Follicular dendritic cell sarcoma |
| ICDO3:9760/3 | Immunoproliferative disease, NOS |
| ICDO3:9761/3 | Waldenstrom macroglobulinemia |
| ICDO3:9762/3 | Heavy chain disease, NOS |
| ICDO3:9764/3 | Immunoproliferative small intestinal disease |
| ICDO3:9765/1 | Monoclonal gammopathy of undetermined significance |
| ICDO3:9766/1 | Angiocentric immunoproliferative lesion |
| ICDO3:9767/1 | Angioimmunoblastic lymphadenopathy (AIC) |
| ICDO3:9768/1 | T-gamma lymphoproliferative disease |
| ICDO3:9769/1 | Immunoglobulin deposition disease |
| ICDO3:9800/3 | Leukemia, NOS |
| ICDO3:9801/3 | Acute leukemia, NOS |
| ICDO3:9805/3 | Acute biphenotypic leukemia |
| ICDO3:9820/3 | Lymphoid leukemia, NOS |
| ICDO3:9823/3 | B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
| ICDO3:9826/3 | Burkitt cell leukemia |
| ICDO3:9827/3 | Adult T-cell leukemia/lymphoma (HTLV-1 positive) |
| ICDO3:9831/3 | T-cell large granular lymphocytic leukemia |
| ICDO3:9832/3 | Prolymphocytic leukemia, NOS |
| ICDO3:9833/3 | Prolymphocytic leukemia, B-cell type |
| ICDO3:9834/3 | Prolymphocytic leukemia, T-cell type |
| ICDO3:9835/3 | Precursor cell lymphoblastic leukemia, NOS |
| ICDO3:9836/3 | Precursor B-cell lymphoblastic leukemia |
| ICDO3:9837/3 | Precursor T-cell lymphoblastic leukemia |
| ICDO3:9840/3 | Acute myeloid leukemia, M6 type |
| ICDO3:9860/3 | Myeloid leukemia, NOS |
| ICDO3:9861/3 | Acute myeloid leukemia, NOS |
| ICDO3:9863/3 | Chronic myeloid leukemia, NOS |
| ICDO3:9866/3 | Acute promyelocytic leukemia |
| ICDO3:9867/3 | Acute myelomonocytic leukemia |
| ICDO3:9870/3 | Acute basophilic leukemia |
| ICDO3:9871/3 | Acute myeloid leukemia with abnormal marrow eosinophils |
| ICDO3:9872/3 | Acute myeloid leukemia, minimal differentiation |
| ICDO3:9873/3 | Acute myeloid leukemia without maturation |
| ICDO3:9874/3 | Acute myeloid leukemia with maturation |
| ICDO3:9875/3 | Chronic myelogenous leukemia, BCR/ABL positive |
| ICDO3:9876/3 | Atypical chronic myeloid leukemia, BCR/ABL negative |
| ICDO3:9891/3 | Acute monocytic leukemia |
| ICDO3:9895/3 | Acute myeloid leukemia with multilineage dysplasia |
| ICDO3:9896/3 | Acute myeloid leukemia, t(8 |
| ICDO3:9897/3 | Acute myeloid leukemia, 11q23 abnormalities |
| ICDO3:9910/3 | Acute megakaryoblastic leukemia |
| ICDO3:9920/3 | Therapy-related acute myeloid leukemia, NOS |
| ICDO3:9930/3 | Myeloid sarcoma |
| ICDO3:9931/3 | Acute panmyelosis with myelofibrosis |
| ICDO3:9940/3 | Hairy cell leukemia |
| ICDO3:9945/3 | Chronic myelomonocytic leukemia, NOS |
| ICDO3:9946/3 | Juvenile myelomonocytic leukemia |
| ICDO3:9948/3 | Aggressive NK-cell leukemia |
| ICDO3:9950/3 | Polycythemia vera |
| ICDO3:9960/3 | Chronic myeloproliferative disease, NOS |
| ICDO3:9961/3 | Myelosclerosis with myeloid metaplasia |
| ICDO3:9962/3 | Essential thrombocythemia |
| ICDO3:9963/3 | Chronic neutrophilic leukemia |
| ICDO3:9964/3 | Hypereosinophilic syndrome |
| ICDO3:9970/1 | Lymphoproliferative disorder, NOS |
| ICDO3:9975/1 | Myeloproliferative disease, NOS |
| ICDO3:9980/3 | Refractory anemia |
| ICDO3:9982/3 | Refractory anemia with sideroblasts |
| ICDO3:9983/3 | Refractory anemia with excess blasts |
| ICDO3:9984/3 | Refractory anemia with excess blasts in transformation |
| ICDO3:9985/3 | Refractory cytopenia with multilineage dysplasia |
| ICDO3:9986/3 | Myelodysplastic syndrome with 5q deletion (5q-) syndrome |
| ICDO3:9987/3 | Therapy-related myelodysplastic syndrome, NOS |
| ICDO3:9989/3 | Myelodysplastic syndrome, NOS |
- Patient
- Consent
- RelatedPathology
- FamilyCancerHistory
- TumorPathologyEvent
- TNM
- Analysis
- ResponseEvaluation
- Biomarker
- Treatment
- AdverseEvent
- Drug
- BiologicalSample
- Technology
- Panel
- AnalysisProcess
- OmicAnalysis
- AlterationOnSample
- Validation
- Alteration
- GenomeEntity
- Fusion
- CNV
- Variant
- Annotation
- VariantInSample
- GeneExpression